Volker Neuschmelting

Prof. Dr. Volker Neuschmelting

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
THTodd Hollon
Todd Hollon
CJCheng Jiang
Cheng Jiang
ACAsadur Chowdury
Asadur Chowdury
MNMustafa Nasir-Moin
Mustafa Nasir-Moin
AKAkhil Kondepudi
Akhil Kondepudi
DODaniel A. Orringer
Daniel A. Orringer

1 February 2013 in NeuroImage
Verified
Journal Article
Closed access
CLCarolin Weiß Lucas
Carolin Weiß Lucas
CNCharlotte Nettekoven
Charlotte Nettekoven
ARAnne K. Rehme
Anne K. Rehme
VNVolker Neuschmelting
Volker Neuschmelting
AEAndrea Eisenbeis
Andrea Eisenbeis
CGChristian Grefkes
Christian Grefkes

18 November 2014 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
HLH. Lockau
H. Lockau
TLT. Liebig
T. Liebig
THT. Henning
T. Henning
VNVolker Neuschmelting
Volker Neuschmelting
HSH. Stetefeld
H. Stetefeld
FDF. Dorn
F. Dorn

1 January 2015 in NeuroImage: Clinical
Verified
Journal Article
Open access
CLCarolin Weiß Lucas
Carolin Weiß Lucas
ITIrada Tursunova
Irada Tursunova
VNVolker Neuschmelting
Volker Neuschmelting
HLHannah Lockau
Hannah Lockau
CNCharlotte Nettekoven
Charlotte Nettekoven
CGChristian Grefkes
Christian Grefkes
Imaging of the course of the corticospinal tract (CST) by diffusion tensor imaging (DTI) is useful for function-preserving tumour surgery. The integration of functional localizer data into tracking algorithms offers to establish a direct structure-function relationship in DTI data. However, alterations of MRI signals in and adjacent to brain tumours often lead to spurious tracking results. We here compared the impact of subcortical seed regions placed at different positions and the influences of the somatotopic location of the cortical seed and clinical co-factors on fibre tracking plausibility in brain tumour patients. The CST of 32 patients with intracranial tumours was investigated by means of deterministic DTI and neuronavigated transcranial magnetic stimulation (nTMS). The cortical seeds were defined by the nTMS hot spots of the primary motor area (M1) of the hand, the foot and the tongue representation. The CST originating from the contralesional M1 hand area was mapped as intra-individual reference. As subcortical region of interests (ROI), we used the posterior limb of the internal capsule (PLIC) and/or the anterior inferior pontine region (aiP). The plausibility of the fibre trajectories was assessed by a-priori defined anatomical criteria. The following potential co-factors were analysed: Karnofsky Performance Scale (KPS), resting motor threshold (RMT), T1-CE tumour volume, T2 oedema volume, presence of oedema within the PLIC, the fractional anisotropy threshold (FAT) to elicit a minimum amount of fibres and the minimal fibre length. The results showed a higher proportion of plausible fibre tracts for the aiP-ROI compared to the PLIC-ROI. Low FAT values and the presence of peritumoural oedema within the PLIC led to less plausible fibre tracking results. Most plausible results were obtained when the FAT ranged above a cut-off of 0.105. In addition, there was a strong effect of somatotopic location of the seed ROI; best plausibility was obtained for the contralateral hand CST (100%), followed by the ipsilesional hand CST (>95%), the ipsilesional foot (>85%) and tongue (>75%) CST. In summary, we found that the aiP-ROI yielded better tracking results compared to the IC-ROI when using deterministic CST tractography in brain tumour patients, especially when the M1 hand area was tracked. In case of FAT values lower than 0.10, the result of the respective CST tractography should be interpreted with caution with respect to spurious tracking results. Moreover, the presence of oedema within the internal capsule should be considered a negative predictor for plausible CST tracking.

6 August 2022 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
DRDavid Reinecke
David Reinecke
NSNiklas von Spreckelsen
Niklas von Spreckelsen
CMChristian Mawrin
Christian Mawrin
AIAdrian Ion-Margineanu
Adrian Ion-Margineanu
GFGina Fürtjes
Gina Fürtjes
VNVolker Neuschmelting
Volker Neuschmelting
Determining the presence of tumor in biopsies and the decision-making during resections is often dependent on intraoperative rapid frozen-section histopathology. Recently, stimulated Raman scattering microscopy has been introduced to rapidly generate digital hematoxylin-and-eosin-stained-like images (stimulated Raman histology) for intraoperative analysis. To enable intraoperative prediction of tumor presence, we aimed to develop a new deep residual convolutional neural network in an automated pipeline and tested its validity. In a monocentric prospective clinical study with 94 patients undergoing biopsy, brain or spinal tumor resection, Stimulated Raman histology images of intraoperative tissue samples were obtained using a fiber-laser-based stimulated Raman scattering microscope. A residual network was established and trained in ResNetV50 to predict three classes for each image: (1) tumor, (2) non-tumor, and (3) low-quality. The residual network was validated on images obtained in three small random areas within the tissue samples and were blindly independently reviewed by a neuropathologist as ground truth. 402 images derived from 132 tissue samples were analyzed representing the entire spectrum of neurooncological surgery. The automated workflow took in a mean of 240 s per case, and the residual network correctly classified tumor (305/326), non-tumorous tissue (49/67), and low-quality (6/9) images with an inter-rater agreement of 89.6% (κ = 0.671). An excellent internal consistency was found among the random areas with 90.2% (Cα = 0.942) accuracy. In conclusion, the novel stimulated Raman histology-based residual network can reliably detect the microscopic presence of tumor and differentiate from non-tumorous brain tissue in resection and biopsy samples within 4 min and may pave a promising way for an alternative rapid intraoperative histopathological decision-making tool.

27 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DRDaniel Rueß
Daniel Rueß
BSBetina Schütz
Betina Schütz
ECEren Celik
Eren Celik
CBChristian Baues
Christian Baues
SJStephanie T. Jünger
Stephanie T. Jünger
MRMaximilian Ingolf Ruge
Maximilian Ingolf Ruge
(1) Background: Transient increase in volume of vestibular schwannomas (VS) after stereotactic radiosurgery (SRS) is common and complicates differentiation between treatment-related changes (pseudoprogression, PP) and tumor recurrence (progressive disease, PD). (2) Methods: Patients with unilateral VS (n = 63) underwent single fraction robotic-guided SRS. Volume changes were classified according to existing RANO criteria. A new response type, PP, with a >20% transient increase in volume was defined and divided into early (within the first 12 months) and late (>12 months) occurrence. (3) Results: The median age was 56 (range: 20–82) years, the median initial tumor volume was 1.5 (range: 0.1–8.6) cm3. The median radiological and clinical follow-up time was 66 (range: 24–103) months. Partial response was observed in 36% (n = 23), stable disease in 35% (n = 22) and PP in 29% (n = 18) of patients. The latter occurred early (16%, n = 10) or late (13%, n = 8). Using these criteria, no case of PD was observed. (4) Conclusion: Any volume increase after SRS for vs. assumed to be PD turned out to be early or late PP. Therefore, we propose modifying RANO criteria for SRS of VS, which may affect the management of vs. during follow-up in favor of further observation.